Literature DB >> 8040313

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats.

C Kouyoumdjian1, S Adnot, M Levame, S Eddahibi, H Bousbaa, B Raffestin.   

Abstract

Exposure to hypoxia and subsequent development of pulmonary hypertension is associated with an impairment of the nitric oxide (NO) mediated response to endothelium-dependent vasodilators. Inhaled NO may reach resistive pulmonary vessels through an abluminal route. The aim of this study was to investigate if continuous inhalation of NO would attenuate the development of pulmonary hypertension in rats exposed to chronic hypoxia. In conscious rats previously exposed to 10% O2 for 3 wk, short-term inhalation of NO caused a dose-dependent decrease in pulmonary artery pressure (PAP) from 44 +/- 1 to 32 +/- 1 mmHg at 40 ppm with no changes in systemic arterial pressure, cardiac output, or heart rate. In normoxic rats, acute NO inhalation did not cause changes in PAP. In rats simultaneously exposed to 10% O2 and 10 ppm NO during 2 wk, right ventricular hypertrophy was less severe (P < 0.01), and the degree of muscularization of pulmonary vessels at both alveolar duct and alveolar wall levels was lower (P < 0.01) than in rats exposed to hypoxia alone. Tolerance to the pulmonary vasodilator effect of NO did not develop after prolonged inhalation. Brief discontinuation of NO after 2 wk of hypoxia plus NO caused a rapid increase in PAP. These data demonstrate that prolonged inhalation of low concentrations of NO induces sustained pulmonary vasodilation and reduces pulmonary vascular remodeling in response to chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040313      PMCID: PMC296133          DOI: 10.1172/JCI117372

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; S R Neish; E Shaffer; S H Abman
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

2.  Inhaled nitric oxide in congenital heart disease.

Authors:  J D Roberts; P Lang; L M Bigatello; G J Vlahakes; W M Zapol
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

3.  Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

Authors:  S Kourembanas; L P McQuillan; G K Leung; D V Faller
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J D Roberts; D M Polaner; P Lang; W M Zapol
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

5.  Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Authors:  J P Cooke; A H Singer; P Tsao; P Zera; R A Rowan; M E Billingham
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

6.  EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs.

Authors:  M Oka; K Hasunuma; S A Webb; T J Stelzner; D M Rodman; I F McMurtry
Journal:  Am J Physiol       Date:  1993-06

7.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

8.  Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.

Authors:  C G Frostell; H Blomqvist; G Hedenstierna; J Lundberg; W M Zapol
Journal:  Anesthesiology       Date:  1993-03       Impact factor: 7.892

9.  Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.

Authors:  S Adnot; C Kouyoumdjian; C Defouilloy; P Andrivet; S Sediame; R Herigault; M D Fratacci
Journal:  Am Rev Respir Dis       Date:  1993-08

10.  Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats.

Authors:  G Barer; C Emery; A Stewart; D Bee; P Howard
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

View more
  21 in total

1.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

3.  Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.

Authors:  Erquan Zhang; Junko Maruyama; Ayumu Yokochi; Yoshihide Mitani; Hirofumi Sawada; Masakatsu Nishikawa; Ning Ma; Kazuo Maruyama
Journal:  J Anesth       Date:  2015-05-01       Impact factor: 2.078

4.  l-Citrulline treatment alters the structure of the pulmonary circulation in hypoxic newborn pigs.

Authors:  Eric B McClellan; Zhengming Wang; Kurt H Albertine; Mark R Kaplowitz; Yongmei Zhang; Candice D Fike
Journal:  Pediatr Pulmonol       Date:  2020-07-24

5.  The role of nitric oxide in the cardiopulmonary response to hypoxia in highland and lowland newborn llamas.

Authors:  Roberto V Reyes; Marcela Díaz; Germán Ebensperger; Emilio A Herrera; Sebastián A Quezada; Ismael Hernandez; Emilia M Sanhueza; Julian T Parer; Dino A Giussani; Aníbal J Llanos
Journal:  J Physiol       Date:  2018-03-02       Impact factor: 5.182

Review 6.  Pulmonary hypertension: NO therapy?

Authors:  S Adnot; B Raffestin
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

Review 7.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

8.  Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome.

Authors:  W Budts; N Van Pelt; H Gillyns; M Gewillig; F Van De Werf; S Janssens
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

9.  Endogenous nitric oxide and pulmonary circulation response to hypoxia in high-altitude adapted Tibetan sheep.

Authors:  Zonghai Ruan; Tomonobu Koizumi; Akio Sakai; Takeshi Ishizaki; Zhangang Wang
Journal:  Eur J Appl Physiol       Date:  2004-08-14       Impact factor: 3.078

10.  Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

Authors:  W Steudel; M Scherrer-Crosbie; K D Bloch; J Weimann; P L Huang; R C Jones; M H Picard; W M Zapol
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.